We are live on
!
Find out more
LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Est. Return
10.14%
This Fund
S&P 500
This Quarter
Est. Return
+7.65%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$939M
AUM Growth
+$86.2M
(+10%)
Cap. Flow
+$29.6M
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
46.18%
Holding
2,925
New
150
Increased
988
Reduced
857
Closed
215
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$5.37M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$2.54M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$2.12M |
| 5 |
NVIDIA
NVDA
|
+$1.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$6.88M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$4.62M |
| 3 |
Oaktree Specialty Lending
OCSL
|
+$825K |
| 4 |
MGI
MoneyGram International, Inc. New
MGI
|
+$627K |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$562K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.18% |
| 2 | Technology | 15.3% |
| 3 | Healthcare | 6.27% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Industrials | 3.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
1001
DELISTED
Blueprint Medicines
BPMC
| $23.6K | ﹤0.01% |
373
+59
| +19% | +$3.21K |
|
1002
Range Resources
RRC
$8.95B
| $23.4K | ﹤0.01% |
796
-27
| -3% | -$735 |
|
1003
Extra Space Storage
EXR
$31.6B
| $23.4K | ﹤0.01% |
157
+37
| +31% | +$5.57K |
|
1004
monday.com
MNDY
$3.94B
| $23.3K | ﹤0.01% |
136
| – | – |
|
1005
First Trust Natural Gas ETF
FCG
$614M
| $23.3K | ﹤0.01% |
+1,000
| New | +$22.7K |
|
1006
Atmos Energy
ATO
$28.8B
| $23.3K | ﹤0.01% |
200
+14
| +8% | +$1.62K |
|
|
X
1007
DELISTED
US Steel
X
| $23.3K | ﹤0.01% |
930
+229
| +33% | +$5.33K |
|
1008
LGI Homes
LGIH
$1.4B
| $23.2K | ﹤0.01% |
172
-14
| -8% | -$1.68K |
|
1009
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.7B
| $23.1K | ﹤0.01% |
672
| – | – |
|
1010
Deluxe
DLX
$1.15B
| $23.1K | ﹤0.01% |
1,319
+1,255
| +1,961% | +$19.7K |
|
1011
American Financial Group
AFG
$12.1B
| $23K | ﹤0.01% |
194
+54
| +39% | +$6.37K |
|
1012
UiPath
PATH
$7.8B
| $23K | ﹤0.01% |
1,388
-126
| -8% | -$2.02K |
|
|
1013
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.7B
| $23K | ﹤0.01% |
310
-61,587
| -99% | -$4.62M |
|
1014
FlexShares STOXX Global Broad Infrastructure Index Fund
NFRA
$3.03B
| $22.9K | ﹤0.01% |
438
| – | – |
|
1015
iShares Core US Aggregate Bond ETF
AGG
$138B
| $22.9K | ﹤0.01% |
+234
| New | +$23.1K |
|
1016
Louisiana-Pacific
LPX
$5.49B
| $22.9K | ﹤0.01% |
305
+6
| +2% | +$371 |
|
1017
Oshkosh
OSK
$9.59B
| $22.9K | ﹤0.01% |
264
+39
| +17% | +$3.07K |
|
1018
Medpace
MEDP
$16.5B
| $22.8K | ﹤0.01% |
95
+5
| +6% | +$1.04K |
|
1019
Ameren
AEE
$30.1B
| $22.7K | ﹤0.01% |
278
-14
| -5% | -$1.2K |
|
|
THS
1020
DELISTED
Treehouse Foods
THS
| $22.7K | ﹤0.01% |
450
-28
| -6% | -$1.44K |
|
1021
Generac Holdings
GNRC
$12.5B
| $22.7K | ﹤0.01% |
152
-42
| -22% | -$4.79K |
|
1022
Evercore
EVR
$11.8B
| $22.5K | ﹤0.01% |
182
+12
| +7% | +$1.38K |
|
1023
Hanover Insurance
THG
$7.98B
| $22.5K | ﹤0.01% |
199
+113
| +131% | +$13.4K |
|
|
FNGA
1024
DELISTED
MicroSectors FANG+ Index 3X Leveraged ETNs due January 8, 2038
FNGA
| $22.5K | ﹤0.01% |
120
-90
| -43% | -$11.8K |
|
1025
Unity
U
$18.9B
| $22.4K | ﹤0.01% |
517
+210
| +68% | +$6.72K |
|
Similar funds
SBIA
CHP
MW
TAM
SIA
CIG
CCM
WCF
Lindbrook Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Lindbrook Capital held 2,925 positions worth $939M, up 10% from $853M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Lindbrook Capital deployed $29.6M of net new capital in Q2 2023, opening 150 new positions and adding to 988 existing holdings. Its largest new stake was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.88M trimmed.
- Lindbrook Capital's largest Q2 2023 buy was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
- Lindbrook Capital added most to Vanguard Total International Stock ETF in Q2 2023, an estimated $5.37M increase.
- Lindbrook Capital's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.88M.
- Lindbrook Capital fully exited MoneyGram International, Inc. New in Q2 2023, selling an estimated $627K.
- Lindbrook Capital's ten largest holdings make up 46% of its $939M portfolio in Q2 2023.
- Lindbrook Capital opened 150 new positions and closed 215 in Q2 2023.
- Lindbrook Capital's portfolio value rose 10% quarter-over-quarter to $939M.
Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.